CME webinar: Addiction Care for the Non-Addiction Provider Part 4 – Overview of Management and Available Resources
Jan. 2022Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, March 23, from noon to 1 p.m. Michael Lynch, MD, Medical Director, Pittsburgh Poison Center; Medical Director, UPMC Health Plan Substance Use Disorder Services; and Assistant Professor of Emergency Medicine, Toxicology, Pediatrics, and Addiction at the University of Pittsburgh, will summarize the continuum of care for a patient with a substance use disorder (SUD) in an outpatient setting, including available resources to assist non-addiction providers with meeting the needs of these patients. This will be part 4 of a 4-part series.
During the program, Dr. Lynch will:
Register today at upmchp.us/ac4. This webinar will be recorded.
You may earn continuing medical education credits for attending this event.*
*Provider is responsible for verifying CME eligibility. This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
During the program, Dr. Lynch will:
- Present data regarding the prevalence and impact of SUDs on society and health care.
- Provide an overview of feasible screening, brief intervention, and referral to treatment processes, including reimbursement opportunities.
- Review basic medical management principles for patients with SUDs.
- Describe existing support and referral resources available to Pennsylvania providers to connect patients to ongoing care.
Register today at upmchp.us/ac4. This webinar will be recorded.
You may earn continuing medical education credits for attending this event.*
*Provider is responsible for verifying CME eligibility. This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, and ASWB. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices
Important announcement – Telehealth submissions
As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.Sep. 2025Important Notices